Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05565638	PROFAST Intervention in Precursor Multiple Myeloma(PROFAST)	completed	N/A	23	Dana-Farber Cancer InstituteOTHER	1	Sep 25, 2025	clinicaltrials
NCT03119883	Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma	completed	N/A	35	Mayo ClinicOTHER	1	Aug 9, 2024	clinicaltrials